Cellular Reprogramming of Human Fibroblasts to Induced Astrocytes Using CRISPRa-Based Transcriptional Activation for Neurodegenerative Disease Modeling

Nino Gvalia
Department: Department of Chemistry and Biochemistry
Program: M.S. in Chemistry
Date: Tuesday, September 15, 2026
Time: 2:00 p.m.
Location: Geology Mathematics Computer Science (GMCS)
Zoom: https://SDSU.zoom.us/j/89460305466
Committee Members
Tom Huxford, Chair, SDSU Chemistry & Biochemistry
Ralph Feuer, SDSU Biology
Christal Sohl, SDSU Chemistry & Biochemistry
Fred H. Gage, Laboratory of Genetics, Salk Institute for Biological Studies
Abstract
Astrocytes are one of the major glial cell types of the central nervous system. They are essential regulators of neuronal homeostasis, synaptogenesis, extracellular ion buffering, neurotransmitter recycling, and neuroinflammatory responses.
Astrocytes actively contribute to aging and neurodegenerative disease, which makes them more important for disease modeling. However, commonly used human in vitro models often fail to preserve donor-age-associated epigenetic markers. In vitro reprogramming through an induced pluripotent stem cell (iPSCs) intermediate state can reset cellular age, making it limited for modeling late-onset neurodegenerative diseases. This thesis investigated a direct reprogramming pathway to generate astrocyte-like cells from donor-derived human dermal fibroblasts while bypassing the pluripotency state.
To directly convert patient-derived human dermal fibroblasts into astrocytes, we used a pooled CRISPR activation (CRISPRa) screen with the combination of the Synergistic Activation Mediator (SAM) system and a GFAP promoter-GFP reporter. We targeted 285 transcription factors (TFs) with 855 guide RNAs (gRNAs) and identified multiple GFP-enriched candidates, with ZFHX4 as a lead candidate for targeted validation. In the following experiments under defined fate-shift and astrocyte- conversion media conditions, endogenous ZFHX4 activation was tested alone and in combination with already known transcription factors SOX9, NFIA, and NFIB (SNN).
During the conversion process, several conditions showed morphological, molecular, and metabolic changes relative to wild-type fibroblasts and CRISPRa machinery controls. ZFHX4 activation was associated with induction of astrocyte markers. However, having similar responses in non-targeting CRISPRa controls showed that these effects were not target-specific. Extracellular L-lactate was increased in several conversion conditions, consistent with metabolic changes.
The conversion strategy was further adapted to a three-dimensional spheroid platform. Spheroids remained structurally intact throughout the conversion process, but several conditions showed progressive reduction in spheroid size. Directly reprogrammed cells also retained fibroblast- like DNA methylation age while being transcriptionally different from the healthy control fibroblasts.
These results identify ZFHX4 as a candidate associated with GFAP reporter activation. However, the response was not specific to ZFHX4-targeted conditions, and additional molecular and functional validation will be required to establish astrocyte identity.
